Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.
about
Metabolic disturbances in diseases with neurological involvementAnimal models and high field imaging and spectroscopyNeurochemical correlates of caudate atrophy in Huntington's disease.Clinical proton MR spectroscopy in central nervous system disordersNeuroimaging in Huntington's disease.Anatomical, functional and molecular biomarker applications of magnetic resonance neuroimaging.Proton Magnetic Resonance Spectroscopy: Relevance of Glutamate and GABA to Neuropsychology.Functional neuroimaging and chorea: a systematic review.Aspartic acid in the hippocampus: a biomarker for postoperative cognitive dysfunctionFunctional connectivity of primary motor cortex is dependent on genetic burden in prodromal Huntington disease.Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects.Early deficits in glycolysis are specific to striatal neurons from a rat model of huntington disease.Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease.Progressive cognitive deficit, motor impairment and striatal pathology in a transgenic Huntington disease monkey model from infancy to adulthood.Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington's DiseaseProton magnetic resonance spectroscopy of the substantia nigra in schizophreniaMagnetic Resonance Image Example-Based Contrast Synthesis.Reductions in the mitochondrial enzyme α-ketoglutarate dehydrogenase complex in neurodegenerative disease - beneficial or detrimental?Huntington disease: a single-gene degenerative disorder of the striatum.Visuospatial Processing Deficits Linked to Posterior Brain Regions in Premanifest and Early Stage Huntington's Disease.Brain metabolite alterations in children with primary nocturnal enuresis using proton magnetic resonance spectroscopy.Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease.Towards an Understanding of Energy Impairment in Huntington's Disease Brain.Expanded neurochemical profile in the early stage of Huntington disease using proton magnetic resonance spectroscopy.Ultra-High Field Proton MR Spectroscopy in Early-Stage Amyotrophic Lateral Sclerosis.Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic.
P2860
Q26999015-C96F7132-45BA-4725-8CFB-DE40B9721E8CQ28662048-443BF30C-4EC2-4F97-8D43-D483626FC8F3Q30737232-921FE6E8-5133-4241-975B-DCB8A0EA4A84Q30764446-7ED8EA5D-A4EB-49D1-9E1B-C0F113BD6C90Q30834004-B568D219-4CE3-428D-BEBD-A8436BDBDB6EQ30910766-9B63BD6C-ACCC-4B3B-9AED-A907F4703113Q30986741-31FCD2E3-CBA2-4760-9CEB-C32B7D49C543Q33820298-C5BE8086-D157-420F-8680-24086F3F002BQ34095665-6E79C876-C0B0-4BA8-AC33-F24C9E6DBE6AQ34096680-15D066AF-33D3-437F-BC9F-4ACD06F0D1B0Q34154830-3D0AC09F-16B2-46F8-9004-0DEF089CB275Q35058593-EDE97F1E-D4D3-4EF9-87A7-A6C48C52440BQ35253106-0D3D9F60-DD91-4334-84D2-C857B75A40CBQ35597258-D0A34A40-990C-46BC-A7C2-3BFF6F5B417EQ35918115-FDA88BC2-3CB8-40C1-B614-9363E447CE61Q37141400-945B38F1-3BD6-4039-952E-E60F7F4E329AQ37640052-D5865917-C061-4AC9-90CF-FF8DCC4C636AQ38748862-6EC4BFD9-EAC5-46F9-862B-7F3E7C536F8EQ38805973-D166714B-A758-4CED-866A-EBEDCFF6DF49Q39155594-872DC938-9AE6-4B40-93E5-5141ED83D0E2Q45173530-CD1151EF-E458-4BC8-9431-E98952CF481AQ45289206-B272333B-80D7-45CD-ABC1-AEBDA5661475Q47442924-89EE4400-D67A-4293-9D8C-13A642BE3C46Q48044131-13CDB665-B16A-4E54-B0B4-3B07FE870BAEQ48337962-AE83A188-72AC-4EA5-B653-1640F63489ABQ54262475-6038A156-FF9E-4DD6-B98B-B2C8A69C5CC9
P2860
Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.
@ast
Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.
@en
type
label
Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.
@ast
Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.
@en
prefLabel
Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.
@ast
Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.
@en
P2093
P2860
P50
P356
P1433
P1476
Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.
@en
P2093
Aaron Carass
Graham W Redgrave
Kenichi Oishi
Megan Shanahan
Paul G Unschuld
Peter B Barker
Richard A E Edden
Russell L Margolis
Susan S Bassett
P2860
P304
P356
10.1002/MDS.25010
P407
P577
2012-05-30T00:00:00Z